ADVISORY/Press Conference Scheduled to Discuss Parkinson's Disease Patient Research Findings Prior to American Neurological Association Annual Meeting.Business Editors/Health/Medical Writers ADVISORY...for Monday (Oct. 20) SAN FRANCISCO--(BUSINESS WIRE)--Oct. 16, 2003 Results of the "Impact of Parkinson's Disease Parkinson's disease or Parkinsonism, degenerative brain disorder first described by the English surgeon James Parkinson in 1817. When there is no known cause, the disease usually appears after age 40 and is referred to as Parkinson's disease. on the Quality of Life" patient-based research study will be revealed in a breakfast panel discussion on Monday, October 20, 2003, from 7:00 - 8:00 a.m. Pacific. The discussion is occurring as neurologists gather in San Francisco for the American Neurological Association's annual meeting, October 19 - 22. The study was commissioned by Amarin Pharmaceuticals (www.amarinpharma.com), sponsored by WE MOVE (Worldwide Education and Awareness for Movement Disorders Movement Disorders Definition Movement disorders are a group of diseases and syndromes affecting the ability to produce and control movement. Description , www.wemove.org) and conducted by the Harris Interactive market research group (www.harrisinteractive.com). Data from a sample of 228 Parkinson's disease patients Famous people, past and present, with Parkinson's include: Living
adj. Causing a loss of strength or energy. Debilitating Weakening, or reducing the strength of. Mentioned in: Stress Reduction effects of "OFF" time, patient's lifestyle modifications, levels of satisfaction with current treatment options, and desired changes for future Parkinson's disease medications. Panel discussion participants will be: -- William Koller, MD, PhD, Professor of Neurology, Mt. Sinai School of Medicine (New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY) -- Matthew B. Stern, MD, Parker Family Professor of Neurology and Director, Parkinson's Disease and Movement Disorders Center, University of Pennsylvania Health System The University of Pennsylvania Health System is a diverse research and clinical care organization in Philadelphia, Pennsylvania that operates under the direction and auspices of the University of Pennsylvania, its umbrella organization Penn Medicine and the University of (Philadelphia, PA) -- Ray Watts, MD, Chairman of Neurology, University of Alabama The University of Alabama (also known as Alabama, UA or colloquially as 'Bama) is a public coeducational university located in Tuscaloosa, Alabama, USA. Founded in 1831, UA is the flagship campus of the University of Alabama System. at Birmingham (Birmingham, AL) -- Judith Blazer, MS, Executive Director, WE MOVE -- Lori Stone, PhD, Senior Research Associate, Harris Interactive
WHAT: Panel discussion of survey results: "Impact of Parkinson's
Disease on the Quality of Life"
WHO: Movement disorder specialists Drs. William Koller, Matthew
Stern and Ray Watts
WE MOVE
Harris Interactive
WHEN: Monday, October 20, 2003
7:00 - 8:00 a.m. Pacific
Interviews available afterward
WHERE: In person: Marriott Hotel, Walnut Room, 55 Fourth Street,
San Francisco, CA
By phone: 888-428-4479; specify "Impact of Parkinson's
Disease on the Quality of Life" teleconference
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion